Sphingolipids as Emerging Mediators in Retina Degeneration

Area of Science:

• Biochemistry
• Cell Biology
• Ophthalmology

Background:

• Sphingolipids (ceramide, S1P, Sph, C1P) are key signaling molecules regulating cellular functions.
• Their roles in retina cell proliferation, survival, migration, neovascularization, inflammation, and death are increasingly recognized.
• Dysregulation of these processes is central to retina degenerative diseases.

Purpose of the Study:

• To review the functions of sphingolipids in various retina cell types.
• To analyze their pathological roles in retina degenerative diseases.
• To identify sphingolipids as potential therapeutic targets for retinal conditions.

Main Methods:

• Literature review of studies on sphingolipids in retina.
• Analysis of sphingolipid roles in normal and pathological retina cell functions.
• Examination of therapeutic potential based on sphingolipid modulation.

Main Results:

• Ceramide (Cer) promotes inflammation and photoreceptor death, but inhibiting its synthesis preserves photoreceptor viability.
• Sphingosine-1-phosphate (S1P) is crucial for retina development and cell survival but can also stimulate Müller glial cell migration, angiogenesis, and fibrosis.
• Ceramide-1-phosphate (C1P) supports photoreceptor survival and differentiation.

Conclusions:

• Sphingolipids play critical roles in regulating retina cell processes.
• Their dysregulation is implicated in the progression of retina degenerations.
• Targeting sphingolipid metabolism offers a promising therapeutic strategy for treating retinal diseases like AMD.